Canaccord Genuity Downgrades AngioDynamics (ANGO) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $12.25 +4.43%
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
Canaccord Genuity downgraded AngioDynamics (NASDAQ: ANGO) from Buy to Hold with a price target of $13.00 (from $14.50).
For an analyst ratings summary and ratings history on AngioDynamics click here. For more ratings news on AngioDynamics click here.
Shares of AngioDynamics closed at $12.14 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Siltronic AG (WAF:GR) (SSLLF) PT Raised to EUR123 at UBS
- TD Cowen Downgrades Enerflex Ltd. (EFX:CN) (EFXT) to Hold
- Morgan Stanley Double Downgrades Dr Lal PathLabs Ltd (DLPL:IN) to Underweight
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
